A pilot study of CS-1008, a humanized monoclonal antibod

Project: Research project

Project Details

Description

A pilot study of CS-1008, a humanized monoclonal antibody targeting death receptor 5, alone or in combination with imatinib mesylate or sunitinib
StatusFinished
Effective start/end date9/25/0712/31/10

Funding

  • Daiichi Sankyo Company, Limited